Back to Search
Start Over
RenovoRx Highlights Acceptance of Abstract for Presentation at ASCO Gastrointestinal Cancers Symposium 2025
- Source :
- Entertainment Close-up. January 22, 2025
- Publication Year :
- 2025
-
Abstract
- RenovoRx, a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, a novel, FDA-cleared delivery platform, reported three abstracts were accepted to be presented at several upcoming industry [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Entertainment Close-up
- Publication Type :
- Periodical
- Accession number :
- edsgcl.824501000